A study in healthy people to test how well repeated doses of BI 3032950 are tolerated

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503332-40-00

Acronym

1486-0002

Enrollment

Registered

2023-08-01

Start date

2023-09-05

Completion date

2024-08-19

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

None listed

Sex/Gender

Male

Age

18 Years to No maximum

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026